Extensive research focusing on non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), evaluating novel therapeutic approaches including immunotherapy combinations and targeted treatments.

Advanced NSCLC Treatments
Immunotherapy Combinations
Targeted Therapies

Multiple trials exploring innovative treatment strategies for both early-stage and metastatic disease.

02 Gastrointestinal Oncology

Studies investigating treatments for colorectal cancer and gastroesophageal cancers, with particular focus on targeted therapies and combination approaches.

Advanced Colorectal Cancer
Gastric Cancer Treatments
Novel Drug Combinations

Research emphasizing personalized treatment approaches based on specific genetic mutations.

03 Other Medical Conditions

Diverse research portfolio including studies on nephrotic syndrome and severe asthma, evaluating new treatment protocols and medication management strategies.

Minimal Change Disease
Severe Allergic Asthma
Treatment Optimization

Focus on improving patient outcomes through innovative therapeutic approaches.

Back to France All countries

Clinical trials in Villefranche sur Saône – page 2

45 trials in Villefranche sur Saône

Non-small cell lung cancer

Study of Repotrectinib for Frail or Elderly Patients with Advanced Non-Small Cell Lung Cancer with ROS1 Gene Rearrangement

Asthma

Study on Stopping Omalizumab in Patients with Well-Controlled Severe Allergic Asthma After 3 Years of Treatment

Tumour of ampulla of Vater

Study Comparing mFOLFIRINOX and Capecitabine or Gemcitabine for Patients with Resected Ampullary Adenocarcinoma

Non-small cell lung cancer metastatic

Study Comparing MK-2870 and Pembrolizumab Combination to Pembrolizumab Alone for Patients with Metastatic Non-Small Cell Lung Cancer with High PD-L1 Levels

Neuroendocrine tumour of the lung

Study on Durvalumab, Etoposide, and Platinum Drug Combination for First-Line Treatment of Advanced Large-Cell Neuroendocrine Lung Cancer Patients

Renal cell carcinoma

Study on Cabozantinib and Drug Combination for Untreated Metastatic Renal Cell Carcinoma in Intermediate and Poor Risk Patients

Gastrooesophageal cancer+3

Study of Oxaliplatin, Nivolumab, and Trifluridine/Tipiracil for Patients with Advanced Gastric, Esophageal, or Gastroesophageal Junction Cancer

Small intestine adenocarcinoma

Study on the Effectiveness of FOLFIRINOX and FOLFOX for Patients with Advanced Small Bowel Cancer Using Calcium Levofolinate, Irinotecan, and Oxaliplatin

Non-small cell lung cancer

Study of N-803, tislelizumab and docetaxel combination versus docetaxel alone for patients with advanced or metastatic non-small cell lung cancer resistant to immune checkpoint inhibitors

Small cell lung cancer limited stage

A Phase III Randomized Trial of Trilaciclib Dihydrochloride versus Placebo in Adults with Limited‑Stage Small Cell Lung Cancer

Ischaemic stroke

Effectiveness of Tenecteplase in Acute Ischemic Stroke Patients Treated 4.5–24 Hours After Onset Before Transfer for Thrombectomy

Non-small cell lung cancer stage III

Durvalumab personalized consolidation immunotherapy after chemoradiotherapy in patients with stage III non‑small cell lung cancer

Filter the trials

Other cities in France

Clinical research in Villefranche sur Saône

Prefer not to search? Our Concierge searches the trials for you.